HOSPIRA MORPHINE SULFATE INJECTION morphine sulfate pentahydrate 30 mg/1 mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

hospira morphine sulfate injection morphine sulfate pentahydrate 30 mg/1 ml injection ampoule

pfizer australia pty ltd - morphine sulfate pentahydrate -

HOSPIRA MORPHINE SULFATE INJECTION morphine sulfate pentahydrate 5 mg/1 mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

hospira morphine sulfate injection morphine sulfate pentahydrate 5 mg/1 ml injection ampoule

pfizer australia pty ltd - morphine sulfate pentahydrate -

MORPHINE MR MYLAN morphine sulfate pentahydrate 100 mg modified release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

morphine mr mylan morphine sulfate pentahydrate 100 mg modified release tablet blister pack

southern cross pharma pty ltd - morphine sulfate pentahydrate, quantity: 100 mg - tablet, modified release - excipient ingredients: hyetellose; povidone; hypromellose; magnesium stearate; purified talc; titanium dioxide; iron oxide black; macrogol 400 - for the management of severe pain where other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. is not indicated as an as-needed (prn) analgesia.

MORPHINE MR MYLAN morphine sulfate pentahydrate 60 mg modified release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

morphine mr mylan morphine sulfate pentahydrate 60 mg modified release tablet blister pack

southern cross pharma pty ltd - morphine sulfate pentahydrate, quantity: 60 mg - tablet, modified release - excipient ingredients: hyetellose; magnesium stearate; purified talc; lactose monohydrate; hypromellose; povidone; titanium dioxide; sunset yellow fcf aluminium lake; macrogol 400 - for the management of severe pain where other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. is not indicated as an as-needed (prn) analgesia.

MORPHINE MR MYLAN morphine sulfate pentahydrate 30 mg modified release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

morphine mr mylan morphine sulfate pentahydrate 30 mg modified release tablet blister pack

southern cross pharma pty ltd - morphine sulfate pentahydrate, quantity: 30 mg - tablet, modified release - excipient ingredients: povidone; hyetellose; magnesium stearate; hypromellose; lactose monohydrate; purified talc; titanium dioxide; indigo carmine; sunset yellow fcf; erythrosine; macrogol 400 - for the management of severe pain where other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. is not indicated as an as-needed (prn) analgesia.

MORPHINE MR MYLAN morphine sulfate pentahydrate 10 mg modified release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

morphine mr mylan morphine sulfate pentahydrate 10 mg modified release tablet blister pack

southern cross pharma pty ltd - morphine sulfate pentahydrate, quantity: 10 mg - tablet, modified release - excipient ingredients: povidone; hypromellose; magnesium stearate; hyetellose; purified talc; lactose monohydrate; titanium dioxide; iron oxide yellow; iron oxide red; macrogol 400 - for the management of severe pain where other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. is not indicated as an as-needed (prn) analgesia.

HOSPIRA MORPHINE SULFATE INJECTION morphine sulfate pentahydrate 10 mg/1 mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

hospira morphine sulfate injection morphine sulfate pentahydrate 10 mg/1 ml injection ampoule

pfizer australia pty ltd - morphine sulfate pentahydrate -

MORPHINE MR AN morphine sulfate pentahydrate 100 mg modified release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

morphine mr an morphine sulfate pentahydrate 100 mg modified release tablet blister pack

southern cross pharma pty ltd - morphine sulfate pentahydrate -

MORPHINE MR AN morphine sulfate pentahydrate 60 mg modified release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

morphine mr an morphine sulfate pentahydrate 60 mg modified release tablet blister pack

southern cross pharma pty ltd - morphine sulfate pentahydrate -

MORPHINE MR AN morphine sulfate pentahydrate 30 mg modified release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

morphine mr an morphine sulfate pentahydrate 30 mg modified release tablet blister pack

southern cross pharma pty ltd - morphine sulfate pentahydrate -